Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (9662)	7/5/1998 1:16:00 AM
From: milton	Read Replies (1) \| Respond to of 14328

Scott Davis: Thanks for the input. It seems a lot of the recent talk has been lacking in info and mainly responsive to the drop in triby's price. A review of triby's fundamentals, its quarter to quarter earnings growth, its positive moves in strategic acquisitions of complementary businesses (centcor, etc) its market depth across 65 countries, and its breadth in products along with its poc focus all support continued growth. I don't see how recent price drops are related to fundamentals, but more likely relate to current market disenchantment with bios and small caps. Triby still has a great future in store.

To: Scott H. Davis who wrote (9662)	7/6/1998 2:26:00 PM
From: gbull	Respond to of 14328

Scott: Yes, it does. You've been hanging around too long. The story will get to you in the end. The reasons you quoted are the long term reasons I stay in Triby. I have done work in doctor's offices and it is part of normal practice to bring testing internally if they can. Handling Lab submissions and results can be a serious pain with lots of hidden overhead. So the story stays good and fundamentals are pretty good. What did happen technically? Looks like we hit the 200 day average and tanked right back to the basic support level of 17/8 - 2. Any TA on that or could it be sunspots? GB in Mem